Vastasyntyne

Vastasyntyne is the Finnish term for a newborn infant, referring to a baby from birth through the first weeks of life. In medical and public health contexts, this period overlaps with what English-speaking professionals call the neonatal period, typically defined as 0 to 28 days after birth.

In newborn care, attention is focused on establishing and stabilizing breathing and circulation, maintaining body temperature, feeding, and monitoring growth and wellbeing. A newborn assessment is commonly performed at birth and again soon after, including general examination and, in many settings, an Apgar score to summarize health immediately after birth. Routine newborn screening and metabolic tests are often performed within the first days or weeks to detect certain conditions early. Parents receive guidance on feeding, hygiene, safe sleep, and signs that require medical attention.

In Finnish-language usage, vastasyntyne often appear in medical records, maternity care guidelines, and early infancy health research. The concept emphasizes the need for early health assessment and parental support during the first weeks of life.